# Genesis Capital

Genesis Capital is a Private Equity based in New York, Australia.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, Australia
- **Region:** Oceania
- **Address:** Sydney, Australia
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** genesiscapital.com.au
- **LinkedIn:** https://www.linkedin.com/company/genesis-capital-llc
- **Wikidata:** Q67808624

## Regulatory record

- **CRD number:** 150035
- **Registration status:** Registered
- **Reports private funds:** No
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/150035

## About

Genesis Capital is an investor in healthcare that partners with leading healthcare businesses to achieve transformational growth and positive health outcomes. It supports high-quality healthcare businesses led by ambitious founders and is thematically-led, investing in healthcare verticals with long-term tailwinds. Headquartered in Sydney, its portfolio spans Australia and New Zealand.

## Sectors

- Healthcare

## People

- Chris Yoo — Founder & Managing Director
- Dr. Michael Caristo — Founder & Managing Director
- Michael Garcia — Managing Director - Finance & Operations
- James Hamlin — Managing Director - Origination
- Ashton Tay — Managing Director
- Tara Hariharan — Associate Director
- Thuy Thai — Associate Director
- Ashleigh Lascelles — Finance Manager
- Joseph Kozera — Investment Manager
- Laura Parmegiani — Investment Manager
- Mackenzie Jones — Investment Manager
- Calvin Lam — Associate
- Paul Han — Associate
- Elaine Yan — Associate
- Shaun Lonstein — Analyst
- Fergal Dillon — Data Analyst
- Nathan Green — Operating Partner
- Ben Wang — Head of Technology
- James Owen — Head of Data and AI
- Corinne Salem — Office Manager
- Justina Simes — Executive Assistant
- David Gordon — Chair - Genesis Capital
- Hon. Greg Hunt — Senior Advisor
- Ian Maynard — Chair - AHTG

## Questions

### What investment stages does Genesis Capital target?

Genesis Capital spans the full lifecycle of private-company finance. Its stated strategy covers early-stage seed and startup rounds, expansion and late-stage growth equity, and mature-company transactions including management buyouts, management buy-ins, and succession-driven recapitalizations. This breadth is unusual — most Australian firms segment into venture or buyout specialists.

### What is Genesis Capital's track record or portfolio?

Specific portfolio companies, fund vintages, and return data are not publicly available. The firm maintains a minimal external footprint, with no disclosed case studies or named investments. Allocators evaluating Genesis should expect to rely entirely on direct due diligence and off-market references.

## Related profiles

- [Genesis Biomed](https://altss.com/profile/genesis-biomed)
- [Genesis Capital Equity](https://altss.com/profile/genesis-capital-equity)

---

Last updated: 2026-08-11T15:06:49.768Z

Canonical page: https://altss.com/profile/genesis-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology